Replies to post #350736 on Anavex Life Sciences Corp (AVXL)

[bb8675309]

Gator328

He’s fine for now. We have several trials in motion, minimal debt, minimal dilution and are starting to attract the attention of institutional investors.

Is he the right CEO for AVXL 5-10 years from now? Maybe, maybe not. His weakness is communication but that’s a skill that comes with experience. His PR mistakes don’t bother me as long as he learns from them and doesn’t repeat them.


Great assessment. Dr. Missling is a young man to accomplish what no man has done before in the CNS space. No company has done this to date. Never a CNS drug trial missed in this space by AVXL. Dr. Missling smart as anyone can tell. This company is worth $75 BilLION with current drug trial results and growing. AVXL cutting edge in the CNS space. imo of course.

Sign Me up for A2-73. Send it to my home. Thanks.

[rayovacAAA]

DOESN'T SEEM LIKE MISSLING IS LEARNING FROM HIS MISTAKES GIVEN AVXL SCREWED UP THE PR RELEASED YESTERDAY!!!!!!!

His PR mistakes don’t bother me as long as he learns from them and doesn’t repeat them.

https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/87242817/anavex-life-sciences-to-present-at-the-11th-annual

Anavex’s lead drug candidate, ANAVEX®2-73 (blarcamesine), successfully completed a Phase 2a clinical trial for Alzheimer’s disease and recently a Phase 2 proof-of-concept study in Parkinson’s disease dementia and a Phase 2 study in adult patients with Rett syndrome.

WE GOT THIS!!!!!!!!

[Bourbon_on_my_cornflakes]

CORRECT: His PR mistakes don’t bother me as long as he learns from them and doesn’t repeat them.

So 21st century to think that PR is more important than the economic reality. To think it is the reality.

PR is annoying, but the real reality is that 273 is heading for approval, that tests are being completed, and that an NDA will be filed this year.

This stock could easily be over $50 by summer as the market focuses on alz and an NDA is submitted for Rett.

I'll take Dr. M's real achievements over another BS-ing biotech CEO anyday.